Poolbeg Pharma engages in the research and development of novel treatments for infectious diseases.
Poolbeg Pharma has raised $5.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.
Poolbeg Pharma's investors include RS Participaties, Disruptive Technologies Innovation Fund, Cathal Friel.
Poolbeg Pharma is headquartered in Dublin, Ireland.
Poolbeg Pharma engages in the research and development of novel treatments for infectious diseases.
Poolbeg Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Poolbeg Pharma — Funding & Investors." VCBacked, June 2, 2025, https://www.vcbacked.co/company/poolbeg-pharma. Accessed September 30, 2026.
VCBacked. (2025). Poolbeg Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/poolbeg-pharma
{{cite web |title=Poolbeg Pharma — Funding & Investors |url=https://www.vcbacked.co/company/poolbeg-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated